Global Cell Culture Market 2014-2018

2014-07-14
Price :
Published : Jul-2014
No. of Pages : 96

Cell culture is the in vitro growth of plant or animal cells for several applications such as research, cell studies, and biopharmaceutical production. Cell culture is a crucial step in tissue engineering and vaccine production. Cell culture instruments and cell culture consumables are necessary for the in vitro production of cell lines. Some essential cell culture instruments are cell culture systems, incubators, biosafety cabinets, and pipetting instruments. These instruments maintain the optimum conditions, such as temperature and humidity, that are essential for cell growth. Cell culture consumables such as media, cell culture reagents, and sera provide the essential nutrients, minerals, and supplements for cell culture.

TechNavio’s analysts forecast the Global Cell Culture market will grow at a CAGR of 10.27 percent over the period 2013-2018.

Covered in this Report

The Global Cell Culture market can be divided into two segments: Cell Culture Instruments and Cell Culture Consumables. This report covers the present scenario and the growth prospects of the Global Cell Culture market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of various products used for cell culture, which include cell culture instruments and cell culture consumables.

TechNavio’s report, the Global Cell Culture Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Cell Culture market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Becton, Dickinson and Co.
  • EMD Millipore
  • GE Healthcare
  • Lonza Group AG
  • Sigma Aldrich Corp.
  • Thermo Fisher Scientific Inc.

Other Prominent Vendors

  • Advanced Instruments
  • Affymetrix
  • Athena
  • Atlanta Biologicals
  • Biological Industries
  • Bioreclamation
  • Bio-Techne
  • Biowest
  • Cell Culture Technologies
  • CellGenix
  • Corning Life Sciences
  • Ependrof
  • Gemini Bio-Products
  • InVitria
  • Irvine Scientific
  • J R Scientific
  • MP Biomedicals
  • Quality Biological
  • Selexis
  • Sera Lab
  • Synthecon
  • VWR International
  • WISENT
  • ZenBio

Key Market Driver

  • Increased Demand for Biopharmaceuticals
  • For a full, detailed list, view our report.

Key Market Challenge

  • Intense Competition Among Vendors.
  • For a full, detailed list, view our report.

Key Market Trend

  • Automation of Cell Culture Systems
  • For a full, detailed list, view our report.

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Biotechnology
Publisher : Technavio
More Reports
Title Price Buy Now

The Biopharmaceutical Industry in 2017: Highlights by Therapeutic Area

The Biopharmaceutical Industry in 2017: Highlights by Therapeutic Area Summary GlobalData's "The Biopharmaceutical Industry in 2017: Highlights by Therapeutic Area", provides an insight-rich overview of the key events and trends that shaped the industry during 2017. Within each of the major therapeutic areas covered, GlobalData's analysts have identified the most impactful happenings during 2017 - such as product launches and label expansions, losses of patent protection and market exclusivity, and key clinical trial data readouts - and provided expert insight on the implications of each event. For the biopharmaceutical industry, 2017 was marked by noteworthy innovation as well as disappointments across therapy areas, set against a backdrop of remarkable advances in technology in he......
$275

Canada Tissue Engineered – Skin Substitute Procedures Outlook to 2024

Canada Tissue Engineered - Skin Substitute Procedures Outlook to 2024 Summary GlobalData's new report, Canada Tissue Engineered - Skin Substitute Procedures Outlook to 2024, provides key procedures data on the Canada Tissue Engineered - Skin Substitute Procedures. The report provides procedure volumes within market segments - Biologic Skin Substitute Procedures, Synthetic Skin Substitute Procedures and Biosynthetic Skin Substitute Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data g......
$2995

Italy Tissue Engineered – Skin Substitute Procedures Outlook to 2024

Italy Tissue Engineered - Skin Substitute Procedures Outlook to 2024 Summary GlobalData's new report, Italy Tissue Engineered - Skin Substitute Procedures Outlook to 2024, provides key procedures data on the Italy Tissue Engineered - Skin Substitute Procedures. The report provides procedure volumes within market segments - Biologic Skin Substitute Procedures, Synthetic Skin Substitute Procedures and Biosynthetic Skin Substitute Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gath......
$2995

North America Tissue Engineered – Skin Substitute Procedures Outlook to 2024

North America Tissue Engineered - Skin Substitute Procedures Outlook to 2024 Summary GlobalData's new report, North America Tissue Engineered - Skin Substitute Procedures Outlook to 2024, provides key procedures data on the North America Tissue Engineered - Skin Substitute Procedures. The report provides procedure volumes within market segments - Biologic Skin Substitute Procedures, Synthetic Skin Substitute Procedures and Biosynthetic Skin Substitute Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use o......
$3995

Spain Tissue Engineered – Skin Substitute Procedures Outlook to 2024

Spain Tissue Engineered - Skin Substitute Procedures Outlook to 2024 Summary GlobalData's new report, Spain Tissue Engineered - Skin Substitute Procedures Outlook to 2024, provides key procedures data on the Spain Tissue Engineered - Skin Substitute Procedures. The report provides procedure volumes within market segments - Biologic Skin Substitute Procedures, Synthetic Skin Substitute Procedures and Biosynthetic Skin Substitute Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gath......
$2995

EU5 Tissue Engineered – Skin Substitute Procedures Outlook to 2024

EU5 Tissue Engineered - Skin Substitute Procedures Outlook to 2024 Summary GlobalData's new report, EU5 Tissue Engineered - Skin Substitute Procedures Outlook to 2024, provides key procedures data on the EU5 Tissue Engineered - Skin Substitute Procedures. The report provides procedure volumes within market segments - Biologic Skin Substitute Procedures, Synthetic Skin Substitute Procedures and Biosynthetic Skin Substitute Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered f......
$3995

Russia Tissue Engineered – Skin Substitute Procedures Outlook to 2024

Russia Tissue Engineered - Skin Substitute Procedures Outlook to 2024 Summary GlobalData's new report, Russia Tissue Engineered - Skin Substitute Procedures Outlook to 2024, provides key procedures data on the Russia Tissue Engineered - Skin Substitute Procedures. The report provides procedure volumes within market segments - Biologic Skin Substitute Procedures, Synthetic Skin Substitute Procedures and Biosynthetic Skin Substitute Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data g......
$2995

Asia-Pacific Tissue Engineered – Skin Substitute Procedures Outlook to 2024

Asia-Pacific Tissue Engineered - Skin Substitute Procedures Outlook to 2024 Summary GlobalData's new report, Asia-Pacific Tissue Engineered - Skin Substitute Procedures Outlook to 2024, provides key procedures data on the Asia-Pacific Tissue Engineered - Skin Substitute Procedures. The report provides procedure volumes within market segments - Biologic Skin Substitute Procedures, Synthetic Skin Substitute Procedures and Biosynthetic Skin Substitute Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of e......
$3995

South Korea Tissue Engineered – Skin Substitute Procedures Outlook to 2024

South Korea Tissue Engineered - Skin Substitute Procedures Outlook to 2024 Summary GlobalData's new report, South Korea Tissue Engineered - Skin Substitute Procedures Outlook to 2024, provides key procedures data on the South Korea Tissue Engineered - Skin Substitute Procedures. The report provides procedure volumes within market segments - Biologic Skin Substitute Procedures, Synthetic Skin Substitute Procedures and Biosynthetic Skin Substitute Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epid......
$2995

BRIC Tissue Engineered – Skin Substitute Procedures Outlook to 2024

BRIC Tissue Engineered - Skin Substitute Procedures Outlook to 2024 Summary GlobalData's new report, BRIC Tissue Engineered - Skin Substitute Procedures Outlook to 2024, provides key procedures data on the BRIC Tissue Engineered - Skin Substitute Procedures. The report provides procedure volumes within market segments - Biologic Skin Substitute Procedures, Synthetic Skin Substitute Procedures and Biosynthetic Skin Substitute Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathere......
$3995